The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Simultaneous Measurement of Thyroxine and Triiodothyronine Peripheral Turnover Kinetics in Man
Open accessAbstract
Serum triiodothyronine (T(3)) kinetics in man have been difficult to define presumably due to the interference of iodoproteins generated during the peripheral metabolism of T(3). The use, in the present study, of an anion-column chromatographic method for separation of serum T(3) as well as thyroxine (T(4)) from these iodoproteins has overcome this technical handicap. Simultaneous measurement of serum (125)I-T(3) and (131)I-T(4) kinetics were performed in 31 subjects from the clinical categories of euthyroid, primary hypothyroid, thyrotoxic and posttreatment hypothyroid Graves' disease, factitial thyrotoxic, and idiopathically high and low thyroxinebinding globulin states. The normal mean T(3) fractional turnover rate (kT(3)) was 0.68 (half-life = 1.0 days), increased in toxic Graves' disease patients to 1.10 (half-life = 0.63 days), and decreased in primary hypothyroid patients to 0.50 (half-life = 1.38 days). The mean T(3) equilibration time averaged 22 hr except in hypothyroid and high thyroxine-binding globulin (TBG) patients where the equilibration period was delayed by 10 hr. The mean T(3) distribution space in normal subjects was 38.4 liters. This was reduced in subjects with high TBG levels (26 liters) and increased in patients with low TBG and in all hyperthyroid states (53-55 liters). The normal serum T(3) concentration was estimated by radioimmunoassay to be 0.106 mug/100 ml. Combined with the mean T(3) clearance value of 26.1 liters/day, the calculated T(3) production rate was 27.6 mug/day. The mean T(3) production rate increased to 201 mug/day in thyrotoxic Graves' disease patients and was reduced to 7.6 mug/day in primary hypothyroid subjects. T(3) production rate was normal in subjects with altered TBG states. The ratio of T(3) to T(4) production rate in normal subjects was 0.31 and was unchanged in patients with altered TBG values. This ratio was increased in all Graves' disease patients with the highest value being 0.81 in the posttreatment hypothyroid Graves' disease group. This apparent preferential production of T(3) may have been responsible for the retention of rapid turnover kinetics for T(3) and T(4) observed in treated Graves' disease patients. The finding that factitial thyrotoxic patients also displayed similar rapid T(3) and T(4) turnover kinetics indicates that these alterations are not a unique feature of Graves' disease per se. When comparing the peripheral turnover values for T(3) and T(4) in man, it is apparent that alterations in metabolic status and serum TBG concentration influence both hormones in a parallel manner; however, changes in metabolic status seem to have a greater influence on T(3) kinetics while alterations in TBG concentrations have a greater effect on T(4). These observations probably relate to the differences in TBG binding affinity and peripheral tissue distribution of these two hormones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radioimmunassay for measurement of triiodothyronine in human serum
Chopra, I. J., Solomon, D. H., & Beall, G. N. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106696 · Cited by 119 · cited 2×
“The recent development of a radioimmunoassay method for measurement of serum T3 in unextracted serum would therefore appear to represent a substantial methodological improvement (11).”
Method
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“The available data relative to the pharmacokinetics of LT3 are contradictory, indicating half-life values ranging from 6 to 22 hours (36,543).”
Dietary-induced alterations in thyroid hormone metabolism during overnutrition.
Danforth, E., Horton, E. S., O'Connell, M., Sims, E. A., Burger, A. G., Ingbar, S. H., Braverman, L., & Vagenakis, A. G. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109590 · Cited by 310
Thyroid Function in Nonthyroidal Illnesses
CHOPRA, I. J., HERSHMAN, J. M., PARDRIDGE, W. M., & NICOLOFF, J. T. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-946 · Cited by 299
Self-citationChopra, I. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108456 · Cited by 291
Kaptein, E. M., Hays, M. T., & Ferguson, D. C. (1994) · Veterinary Clinics of North America: Small Animal Practice · doi:10.1016/s0195-5616(94)50051-2 · Cited by 267
Scientific Opinion on Dietary Reference Values for iodine
EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3660 · Cited by 266
The Effect of Hepatic Enzyme-Inducing Drugs on Thyroid Hormones and the Thyroid Gland*
CURRAN, P. G., & DEGROOT, L. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-135 · Cited by 226
Surks, M. I., Schadlow, A. R., Stock, J. M., & Oppenheimer, J. H. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107244 · Cited by 223
“Our observations are at variance with those of Nicoloff, Low, Dussault, and Fisher (16) and Cavalieri, Steinberg , and Searle (17) who reported no difference in the clearance rates of T3 determined by single compartmental kinetics and by a noncompartmental approach in constant infusion experiments employing euthyroid…”
ResultInfluentialConditions and drugs interfering with thyroxine absorption
Liwanpo, L., & Hershman, J. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.006 · Cited by 222
The role of thyroglobulin in thyroid hormonogenesis
Citterio, C. E., Targovnik, H. M., & Arvan, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0184-8 · Cited by 216
Replacement Dosage of L-Thyroxine in Hypothyroidism: A Re-Evaluation
Stock, J. M., Surks, M. I., & Oppenheimer, J. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403072901001 · Cited by 184
A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism
Colucci, P., Yue, C. S., Ducharme, M., Benvenga, S., Principal Scientist, L. A. C. I., Principal Scientist, L. A. C. I. A. P. C., President and CEO, L. A. C. I., & Professor of Medicine, D. (2010) · European Endocrinology · doi:10.17925/ee.2013.09.01.40 · Cited by 167
Gastrointestinal malabsorption of thyroxine
Virili, C., Antonelli, A., Santaguida, M. G., Benvenga, S., & Centanni, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00168 · Cited by 164
Abuid, J., & Larsen, P. R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107744 · Cited by 156
TSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
Sucralfate causes malabsorption of L-thyroxine
Sherman, S. I., Tielens, E. T., & Ladenson, P. W. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90093-0 · Cited by 105
Pseudomalabsorption of levothyroxine
Ain, K. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470150090036 · Cited by 100
Rodriguez, T., Lavis, V. R., Meininger, J. C., Kapadia, A. S., & Stafford, L. F. (2005) · Endocrine Practice · doi:10.4158/ep.11.4.223 · Cited by 80
Laurberg, P. (1984) · Metabolism · doi:10.1016/0026-0495(84)90203-8 · Cited by 84
The Acute Effect of Calcium Carbonate on the Intestinal Absorption of Levothyroxine
Singh, N., Weisler, S. L., & Hershman, J. M. (2001) · Thyroid · doi:10.1089/105072501753211046 · Cited by 77
“The volume of distribution is correlated to body mass index (BMI) by the following equation (5,12,19,20): V D 5 0.442 3 BMI.”
InfluentialIntrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion
Jing, L., & Zhang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.992883 · Cited by 61
Single-Dose T3 Administration: Kinetics and Effects on Biochemical and Physiological Parameters
Jonklaas, J., Burman, K. D., Wang, H., & Latham, K. R. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000113 · Cited by 49
Hennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Effects of Pharmacological Fiber Supplements on Levothyroxine Absorption
Chiu, A. C., & Sherman, S. I. (1998) · Thyroid® · doi:10.1089/thy.1998.8.667 · Cited by 41
Tanguay, M., Girard, J., Scarsi, C., Mautone, G., & Larouche, R. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.608 · Cited by 33
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
Van Tassell, B., Wohlford, G. F., Linderman, J. D., Smith, S., Yavuz, S., Pucino, F., & Celi, F. S. (2019) · Thyroid® · doi:10.1089/thy.2019.0101 · Cited by 31
“and 6 hours (20,22), and a half-life between 10 and 24 hours (16,20), respectively (Table 4).”
BackgroundThe clinical utility of free thyroxine in oral levothyroxine absorption testing
Ching Sun, G. E., Pantalone, K. M., Faiman, C., Gupta, M., Olansky, L., & Hatipoglu, B. (2014) · Endocrine Practice · doi:10.4158/ep13487.or · Cited by 27
“In the age of the obesity epidemic and given that intracellular fat is not part of the Vd of LT4 (19), using BMI in the calculation appears to be an insurmountable limitation.”
BackgroundThe use of levothyroxine absorption tests in clinical practice
Caron, P., & Declèves, X. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad132 · Cited by 18
Administration and pharmacokinetics of levothyroxine
Lipp, H.-P. (2021) · 70 Years of Levothyroxine · doi:10.1007/978-3-030-63277-9_2 · Cited by 18
Decreased expression of ileal thyroid hormone transporters in a hypothyroid patient: a case report
Chung, C. W., Mo, E. Y., Jung, G. S., Kim, Y. H., Cho, S. W., Park, D. J., Bae, J. M., & Park, Y. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.664839 · Cited by 5
Thyroid function tests and their alterations by drugs
Chopra, I. J., & Solomon, D. H. (1976) · Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics · doi:10.1016/s0362-5486(76)80026-x
Metadata
- Authors
- Nicoloff, J. T., Low, J. C., Dussault, J. H., & Fisher, D. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1972-03-01
- Volume
- 51
- Issue
- 3
- Pages
- 473-483
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1967272642
- Cited by
- 219
- References
- 1
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.